Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HemosIL ReadiPlasTin

K-Number: K213426 · 2022-08-16

Decision Date2022-08-16
Product CodeGJS
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

HemosIL ReadiPlasTin is a medical device manufactured by Instrumentation Laboratory CO. It received FDA 510(k) clearance on 2022-08-16 under approval number K213426. The device is classified under product code GJS. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HemosIL ReadiPlasTin?

HemosIL ReadiPlasTin is a medical device that received FDA 510(k) clearance on 2022-08-16. It is manufactured by Instrumentation Laboratory CO. The 510(k) number is K213426.

When was HemosIL ReadiPlasTin approved by the FDA?

HemosIL ReadiPlasTin received FDA 510(k) clearance on 2022-08-16, under approval number K213426.

What company makes HemosIL ReadiPlasTin?

HemosIL ReadiPlasTin is manufactured by Instrumentation Laboratory CO.

What is the FDA product code for HemosIL ReadiPlasTin?

The FDA product code for HemosIL ReadiPlasTin is GJS.

Other Devices by Instrumentation Laboratory CO

View all 26 devices →

Related Devices (Code: GJS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.